Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cohn

Showing results (691-700 of 730) with videos related to

Pageof 73
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2016
Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy InitiationJyoti S Mathad, Nikhil Gupte, Ashwin Balagopal, et al.
Oncology Reports|September 3, 2009
Identification of candidate epigenetic biomarkers for ovarian cancer detectionYi-Wen Huang, Rachel A Jansen, Enrica Fabbri, et al.
Gynecologic Oncology|January 4, 2021
Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patientsHeather Hampel, Rachel Pearlman, Albert de la Chapelle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2020
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)David S Miller, Virginia L Filiaci, Robert S Mannel, et al.
Gynecologic Oncology|November 25, 2019
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG studyPhuong L Mai, Helen Q Huang, Lari B Wenzel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2015
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257Ighovwerha Ofotokun, Lumine H Na, Raphael J Landovitz, et al.
JNCI Cancer Spectrum|April 28, 2020
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)Phuong L Mai, Austin Miller, Mitchell H Gail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyD Scott McMeekin, David L Tritchler, David E Cohn, et al.
Gastroenterology|June 16, 2016
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair GenesStacey A Cohen, Emily H Turner, Mallory B Beightol, et al.
International Journal of Cancer|October 25, 2017
Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 StudyA S Felix, T M Brasky, D E Cohn, et al.
Pageof 73

Showing results (691-700 of 730) with videos related to

Sort By:
Pageof 73
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2016
Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy InitiationJyoti S Mathad, Nikhil Gupte, Ashwin Balagopal, et al.
Oncology Reports|September 3, 2009
Identification of candidate epigenetic biomarkers for ovarian cancer detectionYi-Wen Huang, Rachel A Jansen, Enrica Fabbri, et al.
Gynecologic Oncology|January 4, 2021
Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patientsHeather Hampel, Rachel Pearlman, Albert de la Chapelle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2020
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)David S Miller, Virginia L Filiaci, Robert S Mannel, et al.
Gynecologic Oncology|November 25, 2019
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG studyPhuong L Mai, Helen Q Huang, Lari B Wenzel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2015
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257Ighovwerha Ofotokun, Lumine H Na, Raphael J Landovitz, et al.
JNCI Cancer Spectrum|April 28, 2020
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)Phuong L Mai, Austin Miller, Mitchell H Gail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyD Scott McMeekin, David L Tritchler, David E Cohn, et al.
Gastroenterology|June 16, 2016
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair GenesStacey A Cohen, Emily H Turner, Mallory B Beightol, et al.
International Journal of Cancer|October 25, 2017
Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 StudyA S Felix, T M Brasky, D E Cohn, et al.
Pageof 73